RSK promotes G2 DNA damage checkpoint silencing by phosphorylating checkpoint kinase 1 (Chk1) at Ser280, and inhibition of RSK can sensitize melanoma cells to DNA‐damaging chemotherapy [210]. Here, CHEK1 is linked to melanoma.